Skip to main content

Gilead Sciences Invests in Research for COVID-19 Treatments for All Ages

By: 3BL Media

SOURCE: Gilead Sciences

DESCRIPTION:

Children are being hospitalized with COVID 19 at increasingly high rates, and those younger than 5 aren't eligible to receive a vaccine. We’re committed to helping in this area by investing in research for COVID-19 treatments for all ages.

About Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

Originally published by Gilead Sciences.

Tweet me: .@GileadSciences is committed to helping children being hospitalized with #COVID19 by investing in research for COVID-19 treatments for all ages. #CROI2022 https://bit.ly/3GNxutP

KEYWORDS: NASDAQ: GILD, COVID-19, CROI2022

Chart showing increase in COVID-19 hospitalizations among children in the US

Recent Quotes

View More
Symbol Price Change (%)
AMZN  201.15
+2.36 (1.19%)
AAPL  263.88
+8.10 (3.17%)
AMD  203.08
-4.24 (-2.05%)
BAC  52.74
+0.19 (0.36%)
GOOG  302.82
-3.20 (-1.05%)
META  639.29
-0.48 (-0.08%)
MSFT  396.86
-4.46 (-1.11%)
NVDA  184.97
+2.16 (1.18%)
ORCL  153.97
-6.17 (-3.85%)
TSLA  410.63
-6.81 (-1.63%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.